LINCOCIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Lincocin, and what generic alternatives are available?
Lincocin is a drug marketed by Pharmacia And Upjohn and Pfizer and is included in two NDAs.
The generic ingredient in LINCOCIN is lincomycin hydrochloride. There are eleven drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the lincomycin hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Lincocin
A generic version of LINCOCIN was approved as lincomycin hydrochloride by XGEN PHARMS on June 4th, 2015.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LINCOCIN?
- What are the global sales for LINCOCIN?
- What is Average Wholesale Price for LINCOCIN?
Summary for LINCOCIN
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 190 |
| Clinical Trials: | 1 |
| Patent Applications: | 3,297 |
| Drug Prices: | Drug price information for LINCOCIN |
| What excipients (inactive ingredients) are in LINCOCIN? | LINCOCIN excipients list |
| DailyMed Link: | LINCOCIN at DailyMed |
Recent Clinical Trials for LINCOCIN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Bristol | Phase 4 |
| University Hospitals Bristol NHS Foundation Trust | Phase 4 |
| Public Health England | Phase 4 |
US Patents and Regulatory Information for LINCOCIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmacia And Upjohn | LINCOCIN | lincomycin hydrochloride | CAPSULE;ORAL | 050316-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Pharmacia And Upjohn | LINCOCIN | lincomycin hydrochloride | CAPSULE;ORAL | 050316-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Pfizer | LINCOCIN | lincomycin hydrochloride | INJECTABLE;INJECTION | 050317-001 | Approved Prior to Jan 1, 1982 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
